Published in J Mol Evol on June 01, 1999
SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity. Genome Res (2000) 1.24
Viral ancestors of antiviral systems. Viruses (2011) 1.11
Genomic plasticity of the MHC class I A region in rhesus macaques: extensive haplotype diversity at the population level as revealed by microsatellites. Immunogenetics (2010) 0.97
Impact of endogenous intronic retroviruses on major histocompatibility complex class II diversity and stability. J Virol (2008) 0.90
Compound evolutionary history of the rhesus macaque MHC class I B region revealed by microsatellite analysis and localization of retroviral sequences. PLoS One (2009) 0.84
The phylogenetic history of the MHC class I gene families in pig, including a fossil gene predating mammalian radiation. J Mol Evol (2003) 0.81
Human endogenous retrovirus (HERVK9) structural polymorphism with haplotypic HLA-A allelic associations. Genetics (2008) 0.78
HLA-A allele associations with viral MER9-LTR nucleotide sequences at two distinct loci within the MHC alpha block. Immunogenetics (2009) 0.75
Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med (1998) 3.62
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity. Arthritis Rheum (1996) 2.28
Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol (1991) 2.27
Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med (1973) 2.25
An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens (2004) 2.20
Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci U S A (1997) 2.10
Disease associations with complotypes, supratypes and haplotypes. Immunol Rev (1983) 1.87
Isolation and characterization of conditional-lethal rho mutants of Escherichia coli. Proc Natl Acad Sci U S A (1977) 1.83
Central MHC genes, IgA deficiency and autoimmune disease. Immunol Today (1990) 1.81
The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics (1999) 1.71
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. Hum Mol Genet (1999) 1.60
Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens (2000) 1.60
Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol (1965) 1.59
Allelic repertoire of the human MHC class I MICA gene. Immunogenetics (1996) 1.57
The genomic sequence and analysis of the swine major histocompatibility complex. Genomics (2006) 1.53
Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol (1992) 1.48
Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers. Tissue Antigens (2012) 1.44
The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet (1999) 1.41
Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci (2000) 1.40
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia. Clin Exp Immunol (1975) 1.38
Laboratory tests in clinical immunology: a critique. Am J Med (1980) 1.34
Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol (1981) 1.32
An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics (1992) 1.32
Isolation and genetic characterization of the nitA mutants of Escherichia coli affecting the termination factor rho. Mol Gen Genet (1976) 1.31
Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis. Clin Exp Immunol (1971) 1.28
Complement allotyping in SLE: association with C4A null. Aust N Z J Med (1983) 1.24
SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity. Genome Res (2000) 1.24
Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics (1986) 1.23
Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol (1979) 1.23
The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J Exp Med (1995) 1.23
Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23
Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS (1992) 1.20
HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia (1983) 1.20
Precise switching of DNA replication timing in the GC content transition area in the human major histocompatibility complex. Mol Cell Biol (1997) 1.20
Molecular dynamics of MHC genesis unraveled by sequence analysis of the 1,796,938-bp HLA class I region. Proc Natl Acad Sci U S A (1999) 1.19
Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med (1993) 1.18
Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA B27. J Rheumatol Suppl (1977) 1.17
Nucleotide sequencing analysis of the 146-kilobase segment around the IkBL and MICA genes at the centromeric end of the HLA class I region. Genomics (1998) 1.15
Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens (1997) 1.14
Nucleotide sequence analysis of the HLA class I region spanning the 237-kb segment around the HLA-B and -C genes. Genomics (1997) 1.13
Pathogenic gene responsible for the predisposition of Behçet's disease. Int Rev Immunol (1997) 1.13
Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex. Gene (1999) 1.12
Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics (1992) 1.11
An analysis of variation in the long-range genomic organization of the human major histocompatibility complex class II region by pulsed-field gel electrophoresis. Genomics (1989) 1.11
Cancer in connective tissue disease. Arthritis Rheum (1982) 1.11
Exposure to blood borne infections in health care workers. Med J Aust (1992) 1.10
The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest (1993) 1.10
Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol (1992) 1.10
HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol (1994) 1.10
A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics (2001) 1.10
Apparent genetic difference between hypothyroid patients with blocking-type thyrotropin receptor antibody and those without, as shown by restriction fragment length polymorphism analyses of HLA-DP loci. J Clin Endocrinol Metab (1993) 1.09
HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology (1992) 1.08
Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum (1981) 1.08
Association of HLA-A24 with complete beta-cell destruction in IDDM. Diabetes (1993) 1.08
Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol (1994) 1.08
HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis. Clin Exp Immunol (1990) 1.07
A new polymorphic and multicopy MHC gene family related to nonmammalian class I. Immunogenetics (1994) 1.07
Family studies of IgA deficiency. Immunogenetics (1985) 1.07
Immunology and functional genomics of Behçet's disease. Cell Mol Life Sci (2003) 1.07
Hepatocellular carcinoma: presentation with vertebral metastases and radicular compression. Cancer (1972) 1.07
Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol (1993) 1.07
Chromosomal localization of the proteasome Z subunit gene reveals an ancient chromosomal duplication involving the major histocompatibility complex. Proc Natl Acad Sci U S A (1996) 1.07
A strong association between HLA-B*5101 and Behçet's disease in Greek patients. Tissue Antigens (1997) 1.06
Human leukocyte antigen-A24 and -DQA1*0301 in Japanese insulin-dependent diabetes mellitus: independent contributions to susceptibility to the disease and additive contributions to acceleration of beta-cell destruction. J Clin Endocrinol Metab (1999) 1.06
Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue Antigens (2007) 1.05
The diagnostic significance of autoantibodies to the acetylcholine receptor. J Neuroimmunol (1982) 1.05
Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet (1980) 1.05
HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. Sleep (1986) 1.04
Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's disease. Hum Immunol (1995) 1.04
Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods (1988) 1.04
HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br Med J (Clin Res Ed) (1983) 1.04
Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. Hum Immunol (1996) 1.04
Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. Tissue Antigens (2006) 1.03
Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells. J Immunol (1989) 1.02
Nucleotide sequence of the human MHC class I MICA gene. Immunogenetics (1996) 1.02
Molecular genetic analysis of myelin-deficient mice: shiverer mutant mice show deletion in gene(s) coding for myelin basic protein. J Neurochem (1985) 1.02
HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens (1992) 1.01
Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece. Invest Ophthalmol Vis Sci (1999) 1.00
New susceptibility locus for high myopia is linked to the uromodulin-like 1 (UMODL1) gene region on chromosome 21q22.3. Eye (Lond) (2008) 1.00
Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol (1990) 0.99
Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative, HLA-DQ beta+ single transgenic mice. J Immunol (1991) 0.99
Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis. Ann N Y Acad Sci (1981) 0.99
Extensive deletions and insertions in different MHC supratypes detected by pusled field gel electrophoresis. J Exp Med (1988) 0.99
Nucleotide sequence of the ring3 gene in the class II region of the mouse MHC and its abundant expression in testicular germ cells. Genomics (1998) 0.99
Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis. Intern Med (1999) 0.99
A boundary of long-range G + C% mosaic domains in the human MHC locus: pseudoautosomal boundary-like sequence exists near the boundary. Genomics (1995) 0.99
Different evolutionary histories in two subgenomic regions of the major histocompatibility complex. Genome Res (1999) 0.99
Twenty-six new polymorphic microsatellite markers around the HLA-B, -C and -E loci in the human MHC class I region. Tissue Antigens (1998) 0.98
Cross-reactivity of anti-acetylcholine receptor autoantibodies. Muscle Nerve (1981) 0.98
Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27. Clin Exp Immunol (1978) 0.98
Genomic anatomy of a premier major histocompatibility complex paralogous region on chromosome 1q21-q22. Genome Res (2001) 0.98
Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. Am J Med (1977) 0.98
Novel cynomolgus macaque MHC-DPB1 polymorphisms in three South-East Asian populations. Tissue Antigens (2006) 0.98
Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51. Invest Ophthalmol Vis Sci (1992) 0.97